Goldman Sachs fumbles $143m Telix block trade, infuriating investors

The Australian Financial Review
03-02

What’s a good time to launch a block trade? According to Goldman Sachs’ equity capital markets team, the answer appears to be 11pm on a Thursday, and hours after a similarly sized sell-down at the same company.

That’s when the Wall Street investment banking giant decided to sell 1.5 per cent of Telix Pharmaceuticals, a Melbourne radiopharmaceuticals specialist with a market capitalisation of more than $9.5 billion, on behalf of China’s Grand Pharma. The next day, thanks to the ill-timed block trade, shares fell 6.3 per cent, wiping half a billion dollars from the company’s valuation.

Loading...

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10